About Arteon Bio
Arteon Bio is a company based in Seongnam-si (South Korea) founded in 2022 by Sohee Choi. Arteon Bio offers products and services including ATN001, ATN002, and ATN003. Arteon Bio operates in a competitive market with competitors including Moderna, BeiGene, Incyte, MorphoSys and Annexon, among others.
- Headquarter Seongnam-si, South Korea
- Founders Sohee Choi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 아테온바이오(주)
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arteon Bio
Arteon Bio offers a comprehensive portfolio of products and services, including ATN001, ATN002, and ATN003.
Pipeline item for biotechnology research and development
Another item in the technology pipeline
Third element in scientific development pipeline
Funding Insights of Arteon Bio
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Seed - Arteon Bio | Valuation |
investors |
Investors in Arteon Bio
Arteon Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HLB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Marine composite materials are manufactured for industry applications.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arteon Bio
Financial Statements - Arteon Bio
Arteon Bio Comparisons
Competitors of Arteon Bio
Arteon Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, MorphoSys and Annexon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
Latest news on Arteon Bio
Frequently Asked Questions about Arteon Bio
Arteon Bio was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Arteon Bio is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Sohee Choi is the current CEO of Arteon Bio. They have also founded this company.
Arteon Bio was founded in 2022 in Seongnam-si, South Korea, within the biotechnology sector. Anti-tumor therapeutics are developed to treat cancer through regulation of the tumor microenvironment. Focus is placed on immunotherapies that modulate immune responses in oncology. Operations involve research and development of targeted treatments, with activities based in South Korea to support global cancer care advancements.
Arteon Bio's top competitors include Moderna, BeiGene and Strand Therapeutics.
Arteon Bio offers ATN001, ATN002, and ATN003.
Arteon Bio has 1 investor. Key investors include HLB.